» Articles » PMID: 19136945

Adaptive Immune Features of Natural Killer Cells

Overview
Journal Nature
Specialty Science
Date 2009 Jan 13
PMID 19136945
Citations 849
Authors
Affiliations
Soon will be listed here.
Abstract

In an adaptive immune response, naive T cells proliferate during infection and generate long-lived memory cells that undergo secondary expansion after a repeat encounter with the same pathogen. Although natural killer (NK) cells have traditionally been classified as cells of the innate immune system, they share many similarities with cytotoxic T lymphocytes. We use a mouse model of cytomegalovirus infection to show that, like T cells, NK cells bearing the virus-specific Ly49H receptor proliferate 100-fold in the spleen and 1,000-fold in the liver after infection. After a contraction phase, Ly49H-positive NK cells reside in lymphoid and non-lymphoid organs for several months. These self-renewing 'memory' NK cells rapidly degranulate and produce cytokines on reactivation. Adoptive transfer of these NK cells into naive animals followed by viral challenge results in a robust secondary expansion and protective immunity. These findings reveal properties of NK cells that were previously attributed only to cells of the adaptive immune system.

Citing Articles

Agent-based modeling of cellular dynamics in adoptive cell therapy.

Wang Y, Casarin S, Daher M, Mohanty V, Dede M, Shanley M bioRxiv. 2025; .

PMID: 40027823 PMC: 11870559. DOI: 10.1101/2025.02.17.638701.


From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy.

Laeremans T, Janssens A, Aerts J Immunotherapy. 2025; 17(2):133-145.

PMID: 39905963 PMC: 11901454. DOI: 10.1080/1750743X.2025.2460965.


Trained immunity in chronic inflammatory diseases and cancer.

Hajishengallis G, Netea M, Chavakis T Nat Rev Immunol. 2025; .

PMID: 39891000 DOI: 10.1038/s41577-025-01132-x.


What's in a name? Memory NK cells for cancer immunotherapy.

Judge S, Purl M, Murphy W, Canter R J Immunother Cancer. 2025; 13(1).

PMID: 39890423 PMC: 11792271. DOI: 10.1136/jitc-2024-010850.


Nanostructured lipid carriers based mRNA vaccine leads to a T cell-inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model.

Fournier C, Mercey-Ressejac M, Derangere V, Al Kadi A, Rageot D, Charrat C EBioMedicine. 2025; 112:105543.

PMID: 39793480 PMC: 11774803. DOI: 10.1016/j.ebiom.2024.105543.


References
1.
Masopust D, Vezys V, Marzo A, Lefrancois L . Preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001; 291(5512):2413-7. DOI: 10.1126/science.1058867. View

2.
Lanier L . NK cell recognition. Annu Rev Immunol. 2005; 23:225-74. DOI: 10.1146/annurev.immunol.23.021704.115526. View

3.
Altman J, Suresh M, Sourdive D, Zajac A, Miller J, Slansky J . Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 1998; 8(2):177-87. DOI: 10.1016/s1074-7613(00)80470-7. View

4.
Glas R, Franksson L, Une C, Eloranta M, Ohlen C, Orn A . Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J Exp Med. 2000; 191(1):129-38. PMC: 2195802. DOI: 10.1084/jem.191.1.129. View

5.
Sun J, Bevan M . Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J Immunol. 2004; 172(6):3385-9. DOI: 10.4049/jimmunol.172.6.3385. View